Abstract Fanconi anemia (FA) family of proteins participates in the DNA repair pathway by homologous recombination, and it is currently formed by 13 genes. Some of these proteins also confer susceptibility to hereditary breast and ovarian cancer (HBOC), since FANCD1 is the BRCA2 breast cancer susceptibility gene, and FANCN/ PALB2 and FANCJ/BRIP1 explain 2% of non-BRCA1/2 HBOC families. Thus, there is an important connection between FA and BRCA pathways. In a previous casecontrol association study analysing FANCA, FANCD2 and FANCL, we reported an association between FANCD2 and sporadic breast cancer (BC) risk (OR = 1.35). In order to know whether variants in other FA genes could also be involved in this association, we have extended our study with the rest of FA genes and some others implicated in the BRCA pathway. We have also analyzed the correlation with survival, nodal metastasis and hormonal receptors (ER-and PR-). A total of 61 SNPs in ten FA genes (FANC-B, -C, -D1, -E, -F, -G, -I, -J, -M, -N) and five FA related genes (ATM, ATR, BRCA1, H2AX and USP1) were studied in a total of 547 consecutive and nonrelated sporadic BC cases and 552 unaffected controls from the Spanish population. Association analyses reported marginal statistically significant results with the minor allele of intronic SNPs in three genes: BRCA1, BRCA2/FANCD1, and ATM. Survival association with SNPs on FANCC and BRCA2/FANCD1 genes were also reported. Sub-group analyses revealed associations between SNPs on FANCI and ATM and nodal metastasis status and between FANCJ/ BRIP1 and FANCN/PALB2 and PR-status.
Introduction
Several breast cancer (BC) susceptibility genes have been identified, the most important high risk genes being the tumor suppressor genes BRCA1 [1] and FANCD1/BRCA2 [2, 3] and other middle-penetrance genes such as ATM [4] , FANCJ/BRIP1 [5] and FANCN/PALB2 [6] , among others. All of these genes are related directly or indirectly to the Fanconi anemia (FA) family of genes, and their coded proteins work together in the homologous recombination DNA repair pathway [7] [8] [9] [10] .
To date, 13 responsible FA genes have been identified [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] : eight of them (FANC-A, -B, -C, -E, -F, -G, -L and -M) code for proteins that form the multi-subunit nuclear FA core complex, two code for proteins that are activated by ubiquitinilation (FANC-I and -D2) and the last three interact with BRCA1 and predispose to breast cancer (FANC-N, -D1 and -J) [25, 26] . Other proteins are also involved in the DNA repair pathway in relation with the function of the FA family of proteins, such as ATM, ATR [27] , BRCA1 [28] , H2AX [29] and USP1 [30] .
Previous work in our group studied the relationship between BC and FANCA, -L and -D2, acting as low penetrance genes (LPG), and results reported an association between the synonymous SNP rs2272125 (L1366L) on FANCD2 and BC (OR per-allele = 1.35; 95% CI. 1.09-1.67; p = 0.005) [31] . This made us to postulate that there could be other members of FA family of genes involved in the sporadic BC risk, because no previous studies had tested this hypothesis. Thus, a comprehensive association study of the rest of FA genes, which includes FANC-B, -C, -D1, -E, -F, -G, -I, -J, -M and -N, together with the five FArelated genes ATM, ATR, BRCA1, H2AX and USP1, and BC risk was performed, comprising a total of 61 SNPs.
Results and discussion
Associations of polymorphisms with BC risk and clinical and tumor characteristics Differences in minor allele frequency (MAF) between BC cases and controls reported association for the noncoding SNPs rs637064 (intronic) on ATM (p = 0.037), rs799923 (intronic) on BRCA1 (p = 0.048), and rs206146 (intronic) and rs15869 (3 0 UTR) on BRCA2/FANCD1 (p = 0.039 and p = 0.033, respectively) (data not shown).
Results from univariate genotype analysis are shown in Table 1 . Both intronic SNPs rs206146 and rs15869 in BRCA2/FANCD1 were statistically significant in a perallele analysis (OR = 1.23, p = 0.040 and OR = 1.24, p = 0.034, respectively), but after a multivariate adjustment, trend but not statistical significance were observed (p = 0.333 and p = 0.344, respectively) (data not shown). No other previous studies described this association since only one study described the association of FANCD1/ BRCA2 with sporadic BC risk [32] , and most of the studies performed analyses of FANCD1/BRCA2 on familial BC type. The BRCA1 SNP rs799923 showed an estimated OR per minor allele of 0.81 (p = 0.041) and OR = 0.77 (p = 0.056) under the multivariate analysis, whereas rs16941, a non-synonymous coding change (G1038E), showed a marginal association with BC (OR = 1.17, p = 0.082), statistically significant after multivariate correction (OR = 1.27, p = 0.037). The estimated OR per minor allele in the ATM SNP rs637064 was 1.19 (p = 0.041). This OR was not statistically significant in the multivariate analysis adjusting for the potential confounding factors: age, number of live births, age at menarche and menopause status (OR = 1.11, p = 0.302), although risk effect was maintained. These two genes have been commonly studied in hereditary BC [33] , but there are few reports in sporadic BC type with contradictory results [34] . No genotype associations were detected in the other FA and FA-related genes tested. Our results in a homogeneous Spanish population group suggest a small implication of some of these FA genes as LPG in breast cancer. However, other evidences have established an important role of FANCF, FANCC and FANCG genes in diverse type of cancers other than BC [17, 35, 36] , and these results could be in agreement with some indirect studies that analyze the cancer risk in carriers of mutation in FA genes [37, 38] .
Despite the small association detection of the other FA gene members with sporadic BC, we tested for SNP association with the four clinical and tumor characteristics: survival, nodal metastasis, ER? and PR?. Several studies have described the BC tumor heterogeneity [33, 39] ; therefore, this issue has been taken into account in sporadic BC association studies by stratification of BC samples [40] . Results are summarized in Table 1 . Two SNPs, one located 3 0 downstream of FANCC, rs1045276 (OR = 1.95, p = 0.020), and a synonymous SNP on BRCA2/FANCD1, rs1801406 (K1132K) (OR = 0.49, p = 0.046), showed association with a poorer and better survival, respectively. However, these survival analyses should be taken with caution since death rate in this sample collection is low, and statistical power is limited. The analysis of the tumor characteristics reported association of nodal metastasis with the intronic SNPs rs7168941 (FANCI) (p = 0.030), but not with BC (p = 0.089). The SNP rs8032440 (FANCI) was associated with absence of nodal metastasis (p = 0.045) and disease (p = 0.048), whereas rs637064 (ATM) showed association with nodal metastasis (p = 0.029) and BC (p = 0.008). These findings are not supported for any other previous study. No statistically significant association with estrogen receptor was detected, whereas positive progesterone receptor was observed among the noncoding SNPs rs7220740 (located at 3 0 downstream of FANCJ/BRIP1) (p = 0.007) and rs447529 (intronic SNP of FANCN/PALB2) (p = 0.030) minor allele carriers. These SNPs were associated with the disease according to the stratified sub-group of PR positive BC samples (p = 0.039 for both of them). Mavaddat and colleagues evaluated progesterone status and did not find any evidence of association with both genes [41] . No other association among genotypes and tumor characteristics was detected. In summary, we have completed the study of the whole FA pathway and some associated genes as LPG. In addition to our FANCD2 BC susceptibility gene description, we have found a trend of association with BC for noncoding SNPs in the already well-described BC high risk genes BRCA1, BRCA2/FANCD1 and ATM. On the other hand, although we recognize that there is potential for misclassification of phenotypic characteristics due to the subjective nature of the phenotypic attributes considered and the limited sample size, we have found an encrypted association with disease in genes FANC-C, -I, -J, -N, ATM and BRCA2/FANCD1. Replication in new independent series for both association studies and phenotypic characteristics are necessary before to confirm or rule out these preliminary results.
